Lessons from thalassaemia screening in Iran

British Medical Journal

Volumn 329, Issue 7475, 2004, Pages 1115-1117

  Christianson, Arnold ^a   Streetly, Allison ^b   Darr, Aamra ^c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; IRON CHELATE;

DEVELOPING COUNTRY; EDITORIAL; ERYTHROCYTE TRANSFUSION; GENETIC COUNSELING; GENETIC SCREENING; HEALTH CARE COST; HEALTH EDUCATION; HEALTH PROGRAM; HETEROZYGOTE; HUMAN; INFANT MORTALITY; IRAN; IRON CHELATION; IRON OVERLOAD; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; THALASSEMIA;

EID: 8744238280     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.329.7475.1115     Document Type: Editorial

References (13)

1. Christianson AL, Modell B. Medical genetics in developing countries. Ann Rev Genomics Hum Genet 2004;5:219-65.
2. Alwan A, Modell B. Recommendations for introducing genetic services in developing countries. Nature Rev Genet 2003;4:61-8.
3. Samavat A, Modell B. Iranian national thalassaemia screening programme. BMJ 2004;329:1134-7.
4. Alwan A, Modell B. 1997. Community control of genetic and congenital disorders. Eastern Mediterranean Regional Office Technical Publication Series 24. 1997. WHO: Regional Office of the Eastern Mediterranean, Alexandria, Egypt.
5. World Health Organization. Primary health care approaches for prevention and control of congenital and genetic disorders. Geneva: WHO, 2000.
6. National Screening Committee (NSC). Criteria far appraising the viability, effectiveness and appropriateness of a screening programme. March 2003. http://rms.nelh.nns.uk/screening/ (accessed 4 Nov 2004).
7. Abdel Haleem MAS. Medical ethics in Islam. In: Grubb A, ed. Choices and decisions in health care. Chichester: John Wiley, 1993:1-20.
8. Ahmed S, Saleem M, Modell B, Petrou M. Screening extended families for genetic haemoglobin disorders in Pakistan. N Engl J Med 2002;347:1162-8.
9. Angastiniotis M, Modell B, Englezos P, Boulyjenkov. Prevention and control of haemoglobinopathies. Bull WHO 1995;73:375-86.
10. Maggio A, Caronia F, Orlandi F. Prenatal diagnosis of haemoglobinopathies in Sicily. Lancet 1992;339:1361-2.
11. Modell B, Harris R, Lane B, Khan M, Darlinson M, Petrou M, et al. Informed choice in genetic screening for thalassaemia during pregnancy: audit from a national confidential enquiry. BMJ 2000;320;325-90.
12. Murtz J. Matching scheme solves Tay Sachs problems. JAMA 1987;258:2636-7.
13. Atkin K, Ahmad WIU. Genetic screening and haemaglobinopathies: ethics, politics and practice. Soc Sci Med 1998;46:445-58.